Neuropathology for the Neuroradiologist: Plaques and Tangles

References

1. ↵
   Möller HJ, Graeber MB. The case described by Alois Alzheimer in 1911: historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci 1998;248:111–22

   CrossRefPubMed
2. Kircher T, Wormstall H. Alois Alzheimer (1864-1915): student days and first scientific activities. J Geriatr Psychiatry Neurol 1997;10:127–29

   Abstract/FREE Full Text
3. ↵
   Brannon WL. Alois Alzheimer (1864–1915). I. Contributions to neurology and psychiatry. J S C Med Assoc 1994;90:399–401

   PubMed
4. ↵
   Beach TG. The history of Alzheimer's disease: three debates. J Hist Med Allied Sci 1987;42:327–49

   FREE Full Text
5. ↵
   Small DH, Cappai R. Alois Alzheimer and Alzheimer's disease: a centennial perspective. J Neurochem 2006;99:708–10

   CrossRefPubMedWeb of Science
6. ↵
   Kreutzberg GW, Gudden W. Alois Alzheimer. Trends Neurosci 1988;11:256–57

   CrossRefPubMed
7. ↵
   Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr Psychiatr 1907;64:146–48
8. ↵
   About a peculiar disease of the cerebral cortex: by Alois Alzheimer, 1907 (translated by L. Jarvik and H. Greenson) [in English and German]. Alzheimer Dis Assoc Disord 1987;1:3–8

   PubMed
9. ↵
   Perusini G. Über klinisch und histologisch eigenartige psychische Erkrankungen des späteren Lebensalters. In: Nissl F, Alzheimer A, eds. Histologische und Histopathologische Arbeiten über die Grosshirnrinde: Mit Besonderer Berücksichtigung der Pathologischen Anatomie der Geisteskrankheiten, Band III, H2. Jena, Germany: Gustav Fischer Verlag;1910 :297–352
10. ↵
    Lucci B. The contribution of Gaetano Perusini to the definition of Alzheimer's disease. Ital J Neurol Sci 1998;19:49–52

    PubMed
11. ↵
    Alzheimer A. Über Eigenartige Krankheitsfalle des Spatern Alters. Gesanipte Neurol Psychiatr 1911;4:356–85
12. ↵
    Klünemann HH, Fronhofer W, Wurster H, et al. Alzheimer's second patient: Johann F. and his family. Ann Neurol 2002;52:520–23

    CrossRefPubMedWeb of Science
13. ↵
    Kraepelin E. Klinische Psychiatrie, part 1. In: Kraepelin E. Psychiatrie: Ein Lehrbuch für Studierende und Artze, Vol. 2. 8 ed. Leipzig, Germany: Barth1910 :627–28
14. Tolliss D. Who was Alzheimer? Nurs Times 1994;90:49

    PubMed
15. Graeber MB, Kosel S, Grasbon-Frodl E, et al. Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D. Neurogenetics 1998;1:223–28

    CrossRefPubMedWeb of Science
16. ↵
    Schorer CE. Historical essay: Kraepelin's description of Alzheimer's disease. Int J Aging Hum Dev 1985;21:235–38

    PubMed
17. ↵
    Tonkonogy J, Moak GS. Alois Alzheimer on presenile dementia. J Geriatr Psychiatry Neurol 1988;1:199–206

    Abstract/FREE Full Text
18. ↵
    Mott RT, Hulette CM. Neuropathology of Alzheimer's disease. Neuroimaging Clin N Am 2005;15:755–65, ix

    CrossRefPubMedWeb of Science
19. ↵
    Vannoy JF, Greene JA. Alzheimer's disease: a brief history. J Tenn Med Assoc 1989;82:15–17

    PubMed
20. Fischer O. Miliare Nekrosen mit drusigen Wucherungen der Neurofibrillen, eine regelmässige Veränderung der Hirnrinde bei seniler Demenz. Monatsschr Psychiatr Neurol 1907;22:361–72

    CrossRef
21. ↵
    Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006;314:777–81

    Abstract/FREE Full Text
22. ↵
    Blocq P, Marinesco G. Sur les lesions et la pathgenie de l'epilepsie dite essentialle. Semaine Med 1892;12:445–46
23. ↵
    Imbimbo BP, Lombard J, Pomara N. Pathophysiology of Alzheimer's disease. Neuroimaging Clin N Am 2005;15:727–53, ix

    CrossRefPubMed
24. ↵
    Ellison D, Love S. Dementias. In: Ellison D, Love S, Chimelli L, et al, eds. Neuropathology: A Reference Text of CNS Pathology. Edinburgh, UK: Mosby,2004 :551–84
25. ↵
    Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 2005;115:1121–29

    CrossRefPubMedWeb of Science
26. ↵
    Schechter R, Yen SH, Terry RD. Fibrous astrocytes in senile dementia of the Alzheimer type. J Neuropathol Exp Neurol 1981;40:95–101

    PubMedWeb of Science
27. ↵
    Wippold FJ 2nd, Perry A, Lennerz J. Neuropathology for the neuroradiologist: Rosenthal fibers. AJNR Am J Neuroradiol 2006;27:958–61

    Abstract/FREE Full Text
28. Gomes FCA, Paulin D, Moura Neto V. Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. Braz J Med Biol Res 1999;32:619–31

    PubMedWeb of Science
29. Rutka JT, Murakami M, Dirks PB, et al. Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 1997;87:420–30

    CrossRefPubMedWeb of Science
30. ↵
    Eng LF, Ghirnikar RS, Lee Y. Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem Res 2000;25:1439–51

    CrossRefPubMedWeb of Science
31. ↵
    Lowe J, Blanchard A, Morrell K, et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1988;155:9–15

    CrossRefPubMedWeb of Science
32. Tomokane N, Iwaki T, Tateishi J, et al. Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not vimentin: immunoelectron microscopy with colloidal gold. Am J Pathol 1991;138:875–85

    PubMedWeb of Science
33. ↵
    Murayama S, Bouldin TW, Suzuki K. Immunocytochemical and ultrastructural studies of eosinophilic granular bodies in astrocytic tumors. Acta Neuropathologica 1992;83:408–14

    CrossRefPubMed
34. ↵
    Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991;12:383–88

    CrossRefPubMedWeb of Science
35. ↵
    Kidd M. Alzheimer's disease: an electron microscopical study. Brain 1964;87:307–20

    FREE Full Text
36. ↵
    Yamaguchi H, Hirai S, Morimatsu M, et al. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol (Berl) 1988;77:113–19

    PubMed
37. ↵
    Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol 2006;44:1–11

    PubMedWeb of Science
38. ↵
    Pearce JM. Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000;68:348

    FREE Full Text
39. ↵
    Sheng JG, Zhou XQ, Mrak RE, et al. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease. J Neuropathol Exp Neurol 1998;57:714–17

    PubMedWeb of Science
40. ↵
    Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239–59

    CrossRefPubMedWeb of Science
41. ↵
    Pastorino L, Lu KP. Pathogenic mechanisms in Alzheimer's disease. Eur J Pharmacol 2006;545:29–38

    CrossRefPubMed
42. ↵
    Delacourte A. Tauopathies: recent insights into old diseases. Folia Neuropathol 2005;43:244–57

    PubMed
43. ↵
    Goedert M, Klug A, Crowther RA. Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis 2006;9:195–207

    PubMedWeb of Science
44. ↵
    Goedert M, Spillantini MG, Davies SW. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 1998;8:619–32

    CrossRefPubMedWeb of Science
45. ↵
    Drachman DA. Aging of the brain, entropy, and Alzheimer disease. Neurology 2006;67:1340–52

    Abstract/FREE Full Text
46. ↵
    Price JL, Davis PB, Morris JC, et al. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295–312

    CrossRefPubMedWeb of Science
47. ↵
    Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann Neurol 1999;45:358–68

    CrossRefPubMedWeb of Science
48. ↵
    Turner RS. Alzheimer's disease. Semin Neurol 2006;26:499–506

    CrossRefPubMed
49. ↵
    Terry RD, Gonatas NK, Weiss MA. Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 1964;44:269–97

    PubMedWeb of Science
50. ↵
    Bayer TA, Wirths O, Majtenyi K, et al. Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol 2001;11:1–11

    PubMedWeb of Science
51. ↵
    Sivaprakasam K. Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation. Curr Med Chem 2006;13:2179–88

    CrossRefPubMedWeb of Science
52. ↵
    Holtzman DM. Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J Mol Neurosci 2001;17:147–55

    CrossRefPubMedWeb of Science
53. ↵
    Golde TE, Eckman CB, Younkin SG. Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim Biophys Acta 2000;1502:172–87

    CrossRefPubMedWeb of Science
54. ↵
    Forero DA, Casadesus G, Perry G, et al. Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. J Cell Mol Med 2006;10:796–805

    CrossRefPubMedWeb of Science
55. ↵
    Mueller SG, Weiner MW, Thal LJ, et al. The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am 2005;15:869–77, xi–ii

    CrossRefPubMedWeb of Science
56. ↵
    Coleman RE. Positron emission tomography diagnosis of Alzheimer's disease. Neuroimaging Clin N Am 2005;15:837–46, x

    CrossRefPubMed
57. Krishnan S, Talley BD, Slavin MJ, et al. Current status of functional MR imaging, perfusion-weighted imaging, and diffusion-tensor imaging in Alzheimer's disease diagnosis and research. Neuroimaging Clin N Am 2005;15:853–68, xi

    CrossRefPubMed
58. ↵
    Lascola C. Molecular imaging in Alzheimer's disease. Neuroimaging Clin N Am 2005;15:827–35, x–xi

    CrossRefPubMed